Skip to main content

Table 3 The 2 year estimated OS and PFS rate in different subgroups

From: Clinical and prognostic analysis of 78 patients with human immuno-deficiency virus associated non-Hodgkin’s lymphoma in Chinese population

  OS (%) PFS (%)
Ann Arbor stage
 I, II 88.6 ± 6.3 68.6 ± 8.3
 III, IV 13.0 ± 10.3 8.4 ± 6.7
Extranodal diseases
 0, 1 71.7 ± 7.8 54.5 ± 7.4
  > 1 10.3 ± 9.5 0
ECOG score
 0, 1 90.2 ± 6.6 73.9 ± 9.2
  > 1 51.4 ± 9.0 20.1 ± 6.7
IPI score
 0, 1 95.0 ± 4.9 80.4 ± 8.8
  > 1 49.6 ± 8.8 19.9 ± 6.4